2022第2屆國際生殖趨勢論壇 強勢登場!
今年(2022)舉辦的第2屆國際生殖趨勢論壇,很榮幸邀請到諸多國內醫界生殖權威醫師,站在以患者為中心的角度,一同分享現今個人化輔助生殖技術應用下,如何有效提升個案懷孕成功率、追蹤並排除後續可能異常風險,以及非侵入性胚胎著床前染色體篩檢(niPGT-A)發展現況之臨床觀點。在個人化生殖檢測技術蓬勃發展的時代,創源攜手醫界專家,深入探討各項檢測的完整分析與追蹤,也持續帶來創新檢測技術的應用與進展。
今年(2022)舉辦的第2屆國際生殖趨勢論壇,很榮幸邀請到諸多國內醫界生殖權威醫師,站在以患者為中心的角度,一同分享現今個人化輔助生殖技術應用下,如何有效提升個案懷孕成功率、追蹤並排除後續可能異常風險,以及非侵入性胚胎著床前染色體篩檢(niPGT-A)發展現況之臨床觀點。在個人化生殖檢測技術蓬勃發展的時代,創源攜手醫界專家,深入探討各項檢測的完整分析與追蹤,也持續帶來創新檢測技術的應用與進展。
This forum will discuss the research and application of personalized reproductive medicine from the perspective of precision medicine. A total of eight physicians and experts from five countries are invited to share their clinical experience and academic viewpoints, and to bring new light to reproductive medicine.
The Malaysian Society for Assisted Reproductive Technology (MSART) will be organising its first ever virtual conference entitled ‘Updates in Fertility’ on the 25th and 26th of September 2021. This conference is open to all specialists and general practitioners as well as medical and nursing staff with an interest in fertility.
We would like to invite you to join us online on 21st July 2021 at 15:40-17:40 (UTC+8) for this multinational forum on stem cell therapy for COVID-19 treatment in Asia. Key experts from 6 countries will share their clinical experience. Free to register.
This webinar has invited doctors and scholars from various countries, including Japan, Malaysia, Singapore, Thailand, Taiwan and other countries, to share the status of cell therapy in their fields and to provide insights on how cell therapy has become a new hope of treatment for severely-affected patients in the pandemic and post-pandemic era.